Modern Diagnost.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE1HK501016
  • NSEID:
  • BSEID: 544673
INR
71.00
0.00 (0.00%)
BSENSE

May 22

BSE+NSE Vol: 4800

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Modern Diagnost. will declare its result soon on 29 May 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.8 k

Shareholding (Mar 2026)

FII

0.03%

Held by 1 FIIs

DII

15.49%

Held by 1 DIIs

Promoter

72.85%

Why is Modern Diagnostic & Research Centre Ltd falling/rising?

22-May-2026

As of 21-May, Modern Diagnostic & Research Centre Ltd's stock price is at 71.00, reflecting a decline of 1.46% and underperforming its sector. The stock is in a bearish trend, trading below all key moving averages and has decreased by 6.89% over the past week.

As of 21-May, Modern Diagnostic & Research Centre Ltd's stock price is falling, currently at 71.00, which reflects a decrease of 1.05 or 1.46%. The stock has underperformed its sector by 2.52% today and has not shown any price movement, trading consistently at the opening price of 71.00. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has declined by 6.89%, while the benchmark Sensex has only decreased by 0.29%. Furthermore, despite a notable increase in delivery volume by 133.33% on May 19, the overall performance remains weak, as the stock has not traded on 2 out of the last 20 days, suggesting erratic trading behavior. Overall, these factors contribute to the stock's current downward trajectory.

View full answer

Which are the latest news on Modern Diagnost.?

22-May-2026
No latest news for Modern Diagnost. found.

When is the next results date for Modern Diagnostic & Research Centre Ltd?

22-May-2026

The next results date for Modern Diagnostic & Research Centre Ltd is 29 May 2026.

The next results date for Modern Diagnostic & Research Centre Ltd is scheduled for 29 May 2026.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 107 Cr (Micro Cap)

stock-summary
P/E

12.00

stock-summary
Industry P/E

63

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.03

stock-summary
Return on Equity

43.28%

stock-summary
Price to Book

5.17

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.5%
0%
-5.5%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Modern Diagnost. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015

21-May-2026 | Source : BSE

Modern Diagnostic & Research Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Modern Diagnostic & Research Centre Limited is scheduled to be held on Friday 29th day of May 2026 inter alia to consider and approve: a. The Quarterly / Annual Financial Statements / Result of the Company for the quarter / year ended 31st March 2026 along with a Statement of Assets & Liabilities and Cash Flow Statement of the Company for the financial year ended on 31st March 2026. b. To take on record the Auditors Report submitted by the Statutory Auditors on the Financial Statements/ Results for the financial year ended on 31st March 2026. c. To consider and transact any other businesses if any which may be placed before the Board with the permission of the Chairman

Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Year Ended 31St March 2026

21-May-2026 | Source : BSE

Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations 2011 for the year ended 31st March 2026

Disclosure Under Regulation 41(4) Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018 For The Year Ended 31St March 2026

15-May-2026 | Source : BSE

Pursuant to Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 please find enclosed herewith the Monitoring Agency Report issued by CARE Ratings Ltd for the year ended 31.03.2026 in respect of utilization of proceeds of IPO of the Company

Corporate Actions stock-summary

stock-summary
BOARD MEETING

29 May 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
5.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
29.56%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.51%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
12
Industry P/E
63
Price to Book Value
5.17
EV to EBIT
9.33
EV to EBITDA
7.15
EV to Capital Employed
3.06
EV to Sales
1.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
32.78%
ROE (Latest)
43.28%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Sideways
KST
Dow Theory
Mildly Bearish
OBV
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.03%)

Promoter with highest holding

Devendra Singh Yadav (61.2%)

Highest Public shareholder

Aarth Aif Growth Fund (4.48%)

Individual Investors Holdings

4.75%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Modern Diagnost."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39.98",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.67",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.95",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.96",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.19%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Modern Diagnost."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "77.95",
          "val2": "67.13",
          "chgp": "16.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.97",
          "val2": "11.05",
          "chgp": "62.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.91",
          "val2": "1.81",
          "chgp": "5.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.97",
          "val2": "5.79",
          "chgp": "54.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.05%",
          "val2": "16.46%",
          "chgp": "6.59%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary

Sep'24
Change(%)
Net Sales
39.98
NA
NA
Operating Profit (PBDIT) excl Other Income
9.67
NA
NA
Interest
0.95
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
4.96
NA
NA
Operating Profit Margin (Excl OI)
24.19%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
77.95
67.13
16.12%
Operating Profit (PBDIT) excl Other Income
17.97
11.05
62.62%
Interest
1.91
1.81
5.52%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.97
5.79
54.92%
Operating Profit Margin (Excl OI)
23.05%
16.46%
6.59%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Modern Diagnostic & Research Centre Ltd stock-summary
stock-summary
Modern Diagnostic & Research Centre Ltd
Micro Cap
Healthcare Services
The Promoter, Mr. Devendra Singh Yadav started its operations of Diagnostic Centre in the name and style of 'Modern X-Ray and Clinical Lab' as Proprietorship firm in year 1985, which was later designated as 'Modern Diagnostic & Research Centre' in 1992. Modern Diagnostic & Research Centre Limited was erstwhile incorporated as "Modern Diagnostic & Research Centre Private Limited" as a private company, vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi .
Company Coordinates stock-summary
Icon
No Company Details Available